Russell Investments Group
ATRS

Russell Investments Group’s Antares Pharma, Inc. ATRS Stock Holding History

Russell Investments Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,045,999
Closed -$12.5M – 3014
2022
Q1 		$12.5M Buy
3,045,999
+1,903,508
+167% +$6.91M 0.02% 733
2021
Q4 		$4.08M Buy
1,142,491
+792,898
+227% +$2.77M 0.01% 1371
2021
Q3 		$1.27M Buy
+349,593
New +$1.41M ﹤0.01% 2077
2020
Q2 		– Sell
-173,156
Closed -$408K – 3231
2020
Q1 		$408K Buy
173,156
+129,875
+300% +$442K ﹤0.01% 2266
2019
Q4 		$203K Hold
43,281
– – ﹤0.01% 2707
2019
Q3 		$145K Buy
+43,281
New +$143K ﹤0.01% 2723
2019
Q2 		– Sell
-434,594
Closed -$1.32M – 2998
2019
Q1 		$1.32M Sell
434,594
-554,218
-56% -$1.8M ﹤0.01% 1922
2018
Q4 		$2.69M Sell
988,812
-121,785
-11% -$401K 0.01% 1461
2018
Q3 		$3.73M Sell
1,110,597
-24,920
-2% -$77K 0.01% 1440
2018
Q2 		$2.93M Buy
1,135,517
+245,032
+28% +$610K 0.01% 1552
2018
Q1 		$1.96M Buy
+890,485
New +$2M ﹤0.01% 1856

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Russell Investments Group's ATRS Position: Q2 2022 in Review

Russell Investments Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 3,045,999 shares — an estimated $12.5M sold.

Russell Investments Group first reported a position in ATRS in Q1 2018 and held it in 11 quarters. The position peaked at $12.5M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Russell Investments Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Russell Investments Group sold 3,045,999 Antares Pharma, Inc. shares in Q2 2022, an estimated $12.5M.
  • Russell Investments Group first reported a position in Antares Pharma, Inc. in Q1 2018 and held it in 11 quarters.
  • Russell Investments Group's Antares Pharma, Inc. position peaked at $12.5M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.